Advancing Biomarkers Analysis Europe 2021

Online Conference

Register now

September 14-16 2021

3:30 PM CET


Lunaphore at Biomarkers Analysis Europe 2021

Join us at the Advancing Biomarkers Analysis Europe Online Conference and follow our exclusive presentation and roundtable discussion.

September 14, 2021


3:30 – 4:00 PM EST


Discussion Topics:

  • Next generation of biomarker evaluation: from IHC to multiplexed IF
  • Advantages of multiplexed IF from basic to clinical research


Prof. Dr. MD Paolo Ascierto

Prof. Dr. MD Paolo Ascierto

Director of the Department of Melanoma, Cancer Immunotherapy and Development Therapeutics Institution

National Tumor Institute – Naples, Italy

Dr. Ascierto is a member of the Steering Committee of Society of Melanoma Research (SMR) and the Board of Directors of Society of ImmunoTherapy of Cancer (SITC).

Dr. MD Carlo Bifulco

Dr. MD Carlo Bifulco

Director of Molecular Pathology and Pathology Informatics at Providence and Director of Translational Molecular Pathology and Molecular Genomics

the Earle A. Chiles Research Institute

Dr. Bifulco serves on the Global Colon Cancer Immunoscore Task Force led by the Society for Immunotherapy of Cancer (SITC) and is co-Chair of the SITC Pathology Task convened to establish multiplexed immunohistochemistry/immunofluorescence (mIHC/IF) standards.

September 14, 2021


1:30 – 1:50 PM EST


Multiplexed immunofluorescence is a technique which can provide unparalleled insight into biomarker expression-based analyses in tissue, including studying the interaction of different cell types in the tumor microenvironment using a single tissue section. One of the challenging aspects related to this technique is the optimization of new markers and building marker panels of interest. Here, we present a fast, robust and automated method for optimizing hyper-plex panels using the COMET™ technology


Dr. Saska Brajkovic

Dr. Saska Brajkovic

Head of Application Development


Related Events